COVID-19 postponement of MDR implementation date – how does this fit with Brexit?
par Adrian Toutoungi
Ex parte injunctions in the Netherlands
par Maarten Rijks
COVID-19: Courts and IP offices in the Netherlands
par Dr. Wim Maas et Maarten Rijks
Managing chaos – how will entrepreneurs cope with the upcoming crisis?
par plusieurs auteurs
German Federal Court of Justice Hearing on FRAND
The deadlock on the unified patent convention
The decision of the Federal Constitutional Court (Case No 2 BvR 739/17) on the constitutionality of the UPC-Act of Approval
Everything biologic and biosimilar in-house counsel need to know about COVID-19
par plusieurs auteurs
Video conferencing in patent disputes
Patent pools: an easy licensing option for COVID-19 drugs and SARS CoV 2 vaccines?
An exploration of patent pools, R&D and current initiatives.
par Dr. Anja Lunze, LL.M. et Dr. Jan Phillip Rektorschek
2 de 6 Publications
COVID-19 and public compulsory licensing of drugs in Europe
par plusieurs auteurs